Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Neoplasms of the CNS

Free Subscription 01.04.2024 1 Acta Neuropathol 1 AJNR Am J Neuroradiol 3 BMC Cancer 1 BMC Neurol 9 Childs Nerv Syst 1 Clin Cancer Res 1 Eur J Cancer 1 J Clin Oncol 2 J Neurol 8 J Neurooncol 1 J Neurosurg 1 PLoS One 1 Pol J Radiol 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. REDMER T, Schumann E, Peters K, Weidemeier ME, et al
   Correction to: MET receptor serves as a promising target in melanoma brain metastases.
   Acta Neuropathol. 2024;147:63.
   PubMed        
   
   

   
   AJNR Am J Neuroradiol

2. KERSCH CN, Kim M, Stoller J, Barajas RF Jr, et al
   Imaging Genomics of Glioma Revisited: Analytic Methods to Understand Spatial and Temporal Heterogeneity.
   AJNR Am J Neuroradiol. 2024 Mar 28. doi: 10.3174/ajnr.A8148.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. WANG G, Ren X, Li J, Cui R, et al
   High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade.
   BMC Cancer. 2024;24:385.
   PubMed         Abstract available
   
   
4. ZHANG W, Blank A, Kremenetskaia I, Nitzsche A, et al
   CD13 expression affects glioma patient survival and influences key functions of human glioblastoma cell lines in vitro.
   BMC Cancer. 2024;24:369.
   PubMed         Abstract available
   
   
5. MA Y, Gong Y, Qiu Q, Ma C, et al
   Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma.
   BMC Cancer. 2024;24:363.
   PubMed         Abstract available
   
   

   
   BMC Neurol

6. GIBSON D, Vo AH, Lambing H, Bhattacharya P, et al
   A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM].
   BMC Neurol. 2024;24:103.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

7. KURNER K, Greuter L, Roethlisberger M, Brand Y, et al
   Pediatric sellar teratoma - Case report and review of the literature.
   Childs Nerv Syst. 2024;40:1259-1270.
   PubMed         Abstract available
   
   
8. LEE JS, Lee JY, Park SH, Wang KC, et al
   Intramedullary spinal capillary hemangioma with secondary neurulation defect in children.
   Childs Nerv Syst. 2024;40:1287-1294.
   PubMed         Abstract available
   
   
9. GAGGERO G, Vitulli F, Ramaglia A, Antico A, et al
   Rathke's cyst with xanthogranulomatous change or chronic cystic craniopharingioma? A rare case.
   Childs Nerv Syst. 2024;40:1311-1314.
   PubMed         Abstract available
   
   
10. DROZDZ A, Wojciechowski T, Ciszek B, Stopa Z, et al
    Large intradiploic arachnoid cyst of the skull in child-a case report and new terminology proposition.
    Childs Nerv Syst. 2024;40:1271-1276.
    PubMed         Abstract available
    
    
11. CASADO-RUIZ J, Ros B, Iglesias S, Ros A, et al
    Spinal cord lipomas: lessons learned in the era of total resection.
    Childs Nerv Syst. 2024;40:1121-1128.
    PubMed         Abstract available
    
    
12. KIM TK, Kim JW, Kim SK, Lee JY, et al
    Surgical treatment of interhemispheric arachnoid cysts.
    Childs Nerv Syst. 2024;40:1169-1176.
    PubMed         Abstract available
    
    
13. OGURA R, Fujiwara H, Natsumeda M, Hiraishi T, et al
    Preoperative interactive virtual simulation applying three-dimensional multifusion images using a haptic device for lumbosacral lipoma.
    Childs Nerv Syst. 2024;40:1129-1136.
    PubMed         Abstract available
    
    
14. BALI B, Sellers A, Chinea A, Jallo GI, et al
    Intramedullary spinal cord tumors in pediatric patients presenting later with brain lesions: case series and systematic review of the literature.
    Childs Nerv Syst. 2024;40:1079-1089.
    PubMed         Abstract available
    
    
15. PAPANGELOPOULOU D, Bison B, Behrens L, Bailey S, et al
    Brain stem tumors in children less than 3 months: Clinical and radiologic findings of a rare disease.
    Childs Nerv Syst. 2024;40:1053-1064.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

16. DESAI PB, Karve A, Zawit M, Arora P, et al
    A Phase 0/1 Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas.
    Clin Cancer Res. 2024 Mar 26. doi: 10.1158/1078-0432.CCR-23-3341.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

17. PICCA A, Touat M, Belin L, Gourmelon C, et al
    REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas.
    Eur J Cancer. 2024;202:114034.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

18. XIAO H, Vaidya R, Hershman DL, Unger JM, et al
    Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022.
    J Clin Oncol. 2024 Mar 27:JCO2301777. doi: 10.1200/JCO.23.01777.
    PubMed         Abstract available
    
    

    
    J Neurol

19. AZZIMONTI M, Margoni M, Zanetta C, Genovese F, et al
    Tumefactive demyelinating lesions: a challenging first manifestation of multiple sclerosis.
    J Neurol. 2023 Dec 28. doi: 10.1007/s00415-023-12164.
    PubMed        
    
    
20. LI EC, Lai QL, Cai MT, Fang GL, et al
    Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): contemporary advances and current controversies.
    J Neurol. 2024;271:1747-1766.
    PubMed         Abstract available
    
    

    
    J Neurooncol

21. WATANABE G, Young K, Rauber E, Khan MF, et al
    A systematic review of extraneural meningioma metastasis: timing, evolution and outlook.
    J Neurooncol. 2024 Mar 26. doi: 10.1007/s11060-024-04659.
    PubMed         Abstract available
    
    
22. STRAUBE C, Combs SE, Bernhardt D, Gempt J, et al
    Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers.
    J Neurooncol. 2024 Mar 23. doi: 10.1007/s11060-024-04633.
    PubMed         Abstract available
    
    
23. ANDREWS CE, Zilberberg J, Perez-Olle R, Exley MA, et al
    Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy.
    J Neurooncol. 2024 Mar 22. doi: 10.1007/s11060-024-04635.
    PubMed        
    
    
24. ZAKI PG, Herr S, Shepard MJ
    Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis.
    J Neurooncol. 2024 Mar 22. doi: 10.1007/s11060-024-04602.
    PubMed        
    
    
25. SHEEHAN JP, Singh R, Trifiletti DM
    Stereotactic radiosurgery for intracranial adenoid cystic carcinoma.
    J Neurooncol. 2024;167:229-230.
    PubMed        
    
    
26. WILSON JS, Main C, Thorp N, Taylor RE, et al
    The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review.
    J Neurooncol. 2024;167:1-34.
    PubMed         Abstract available
    
    
27. RANADE M, Epari S, Shetty O, Dhanavade S, et al
    CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization.
    J Neurooncol. 2024;167:189-198.
    PubMed         Abstract available
    
    
28. FLORES-PACO P, Vargas-Aliaga A, Guevara MG, Lopera I, et al
    A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.
    J Neurooncol. 2024 Mar 27. doi: 10.1007/s11060-024-04618.
    PubMed         Abstract available
    
    

    
    J Neurosurg

29. TABOR JK, Dincer A, O'Brien J, Lei H, et al
    Variations in the genomic profiles and clinical behavior of meningioma by racial and ethnic group.
    J Neurosurg. 2024 Mar 22:1-9. doi: 10.3171/2024.1.JNS231633.
    PubMed         Abstract available
    
    

    
    PLoS One

30. JIN X, Zhu J, Yu H, Shi S, et al
    Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.
    PLoS One. 2024;19:e0298055.
    PubMed         Abstract available
    
    

    
    Pol J Radiol

31. TRIVEDI KH, Guha A, Thakur M, Mahajan A, et al
    External validation of the Brain Tumour Reporting and Data System (BT-RADS) in the multidisciplinary managementof post-treatment gliomas.
    Pol J Radiol. 2024;89:e148-e155.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

32. WU R, Sun C, Chen X, Yang R, et al
    NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion.
    Proc Natl Acad Sci U S A. 2024;121:e2321611121.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.